Reckitt Benckiser Group PLC
RKT: XLON (GBR)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|M& | LOCK|%! | LOCK|bwsTq? |
Reckitt Benckiser: Weak Flu Season and Geopolitical Issues in Emerging Markets Weigh on Sales
Reckitt reported modest 0.6% like-for-like sales growth in the first quarter, with the core portfolio up 1.3%, below the company-compiled consensus and substantially decelerating sequentially, however, 2026 guidance was confirmed. Shares fell 6% intraday on April 22.
